|
|
 Previous Article | Table of Contents | Next Article 
Roles of the N and C terminal domains of the interleukin-3 receptor alpha
chain in receptor function
SC Barry, E Korpelainen, Q Sun, FC Stomski, PA Moretti, H Wakao, RJ D'Andrea, MA Vadas, AF Lopez and GJ Goodall
Hanson Centre for Cancer Research, Adelaide, Australia.
The interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor,
and IL-5 receptor alpha chains are each composed of three extracellular
domains, a transmembrane domain and a short intracellular region. Domains 2
and 3 constitute the cytokine receptor module (CRM), typical of the
cytokine receptor superfamily; however, the function of the N-terminal
domain is not known. We have investigated the functions of the N-terminal
and C-terminal domains of the IL-3 receptor (IL-3R) alpha chain. We find
that cells transfected with the receptor beta chain (h beta c) and a
truncated IL-3R alpha that is devoid of the intracellular region fail to
proliferate or to activate STAT5 in response to human IL-3, despite binding
the IL-3 with affinity indistinguishable from that of full-length receptor.
In addition, IL-3- induced phosphorylation of h beta c was not detected.
Thus, the IL-3R alpha intracellular region does not contribute detectably
to stabilization of the receptor/ligand complex, but is essential for
signal propagation. In contrast, a truncated IL-3R alpha with the N-
terminal domain deleted interacts functionally with the beta chain; mouse
cells transfected with these receptor chains proliferate in response to
human IL-3 and STAT5 transcription factor is activated. High- and
low-affinity binding sites are retained, although the affinity for IL-3 is
decreased 15-fold, indicating a significant role for the N-terminal domain
in IL-3 binding.
Volume 89,
Issue 3,
pp. 842-852,
02/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. M. Hassanein, F. Alcancia, K. R. Perkinson, P. J. Buckley, and A. S. Lagoo
Distinct Expression Patterns of CD123 and CD34 on Normal Bone Marrow B-Cell Precursors ("Hematogones") and B Lymphoblastic Leukemia Blasts
Am J Clin Pathol,
October 1, 2009;
132(4):
573 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, J. Olsen, S. Ford, S. Mirza, A. Walker, J. M. Murphy, and I. G. Young
A New Isoform of Interleukin-3 Receptor {alpha} with Novel Differentiation Activity and High Affinity Binding Mode
J. Biol. Chem.,
February 27, 2009;
284(9):
5763 - 5773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Dulkys, C. Kluthe, T. Buschermohle, I. Barg, S. Kno{beta}, A. Kapp, A. E. I. Proudfoot, and J. Elsner
IL-3 Induces Down-Regulation of CCR3 Protein and mRNA in Human Eosinophils
J. Immunol.,
September 15, 2001;
167(6):
3443 - 3453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Le, F. Stomski, J. M. Woodcock, A. F. Lopez, and T. J. Gonda
The Role of Disulfide-linked Dimerization in Interleukin-3 Receptor Signaling and Biological Activity
J. Biol. Chem.,
February 18, 2000;
275(7):
5124 - 5130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Evans, A. Pierce, S. A. Winter, E. Spooncer, C. M. Heyworth, and A. D. Whetton
Activation of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Receptor Subunits in a Multipotential Hematopoietic Progenitor Cell Line Leads to Differential Effects on Development
Blood,
September 1, 1999;
94(5):
1504 - 1514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. C. Orban, M. K. Levings, and J. W. Schrader
Heterodimerization of the alpha and beta Chains of the Interleukin-3 (IL-3) Receptor Is Necessary and Sufficient for IL-3-Induced Mitogenesis
Blood,
September 1, 1999;
94(5):
1614 - 1622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Jenkins, F. Le, and T. J. Gonda
A Cell Type-specific Constitutive Point Mutant of the Common beta -Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Interleukin (IL)-3, and IL-5 Receptors Requires the GM-CSF Receptor alpha -Subunit for Activation
J. Biol. Chem.,
March 26, 1999;
274(13):
8669 - 8677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Jenkins, T. J. Blake, and T. J. Gonda
Saturation Mutagenesis of the beta Subunit of the Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor Shows Clustering of Constitutive Mutations, Activation of ERK MAP Kinase and STAT Pathways, and Differential beta Subunit Tyrosine Phosphorylation
Blood,
September 15, 1998;
92(6):
1989 - 2002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
